Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Jun;57(6):1626–1634. doi: 10.1172/JCI108433

Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

S I Rosenfeld, M E Kelly, J P Leddy
PMCID: PMC436822  PMID: 932197

Abstract

The first recognized human kindred with hereditary deficiency of the fifth component of complement (C5) is described. The proband, a 20-year-old black female with systemic lupus erythematosus since age 11, lacked serum hemolytic complement activity, even during remission. C5 was undetectable in her serum by both immunodiffusion and hemolytic assays. Other complement components were normal during remission of lupus, but C1, C4, C2, and C3 levels fell during exacerbations. A younger half-sister, who had no underlying disease, was also found to lack immunochemically detectable C5. By hemolytic assay, she exhibited 1-2% of the normal serum C5 level and normal concentrations of other complement components. C5 levels of other family members were either normal or approximately half-normal, consistent with autosomal codominant inheritance of the gene determining C5 deficiency. Normal hemolytic titers were restored to both homozygous C5-deficient (C5D) sera by addition of highly purified human C5. In specific C5 titrations, however, it was noted that when limited amounts of C5 were assayed in the presence of low dilutions of either C5D serum, curving rather than linear dose-response plots were consistently obtained, suggesting some inhibitory effect. Further studies suggested that low dilutions of C5D serum contain a factor (or factors) interfering at some step in the hemolytic assay of C5, rather than a true C5 inhibitor or inactivator. Of clinical interest are (a) the documentation of membranous glomerulonephritis, vasculitis, and arthritis in an individual lacking C5 (and its biologic functions), and (b) a remarkable propensity to bacterial infections in the proband, even during periods of low-dose or alternate-day corticosteroid therapy. Other observations indicate that the C5D state is compatible with normal coagulation function and the capacity to mount a neutrophilic leukocytosis during pyogenic infection.

Full text

PDF
1626

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballow M., Shira J. E., Harden L., Yang S. Y., Day N. K. Complete absence of the third component of complement in man. J Clin Invest. 1975 Sep;56(3):703–710. doi: 10.1172/JCI108141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell D. A., Leblond P. F., Leddy J. P., Lauf P. K., LaCelle P. L., Weed R. I. Immune hemolysis. I. Differing susceptibility of three genetic types of sheep red cells. J Immunol. 1972 Feb;108(2):467–474. [PubMed] [Google Scholar]
  3. Boyer J. T., Gall E. P., Norman M. E., Nilsson U. R., Zimmerman T. S. Hereditary deficiency of the seventh component of complement. J Clin Invest. 1975 Oct;56(4):905–913. doi: 10.1172/JCI108170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caren L. D., Rosenberg L. T. The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri. J Exp Med. 1966 Oct 1;124(4):689–699. doi: 10.1084/jem.124.4.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Day N. K., L'Esperance R., Good R. A., Michael A. F., Hansen J. A., Dupont B., Jersild C. Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med. 1975 Jun 1;141(6):1464–1469. doi: 10.1084/jem.141.6.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fu S. M., Kunkel H. G., Brusman H. P., Allen F. H., Jr, Fotino M. Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med. 1974 Oct 1;140(4):1108–1111. doi: 10.1084/jem.140.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fu S. M., Stern R., Kunkel H. G., Dupont B., Hansen J. A., Day N. K., Good R. A., Jersild C., Fotino M. Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med. 1975 Aug 1;142(2):495–506. doi: 10.1084/jem.142.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  9. Lanier B. G., McDuffie F. C., Holley K. E. Role of C5 in the nephritis of NZB-W mice. J Immunol. 1971 Mar;106(3):740–746. [PubMed] [Google Scholar]
  10. Leddy J. P., Frank M. M., Gaither T., Baum J., Klemperer M. R. Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies. J Clin Invest. 1974 Feb;53(2):544–553. doi: 10.1172/JCI107588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leddy J. P., Griggs R. C., Klemperer M. R., Frank M. M. Hereditary complement (C2) deficiency with dermatomyositis. Am J Med. 1975 Jan;58(1):83–91. doi: 10.1016/0002-9343(75)90537-9. [DOI] [PubMed] [Google Scholar]
  12. Morelli R., Rosenberg L. T. Role of complement during experimental Candida infection in mice. Infect Immun. 1971 Apr;3(4):521–523. doi: 10.1128/iai.3.4.521-523.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  14. Nilsson U. R., Tomar R. H., Taylor F. B., Jr Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis. Immunochemistry. 1972 Jul;9(7):709–723. doi: 10.1016/0019-2791(72)90015-8. [DOI] [PubMed] [Google Scholar]
  15. Osterland C. K., Espinoza L., Parker L. P., Schur P. H. Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med. 1975 Mar;82(3):323–328. doi: 10.7326/0003-4819-82-3-323. [DOI] [PubMed] [Google Scholar]
  16. Polley M. J., Müller-Eberhard H. J. Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967 Dec 1;126(6):1013–1025. doi: 10.1084/jem.126.6.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosenfeld S. I., Baum J., Steigbigel R. T., Leddy J. P. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum. J Clin Invest. 1976 Jun;57(6):1635–1643. doi: 10.1172/JCI108434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rosenfeld S. I., Ruddy S., Austen K. F. Structural polymorphism of the fourth component of human complement. J Clin Invest. 1969 Dec;48(12):2283–2292. doi: 10.1172/JCI106194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ruddy S., Austen K. F. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3. J Immunol. 1969 Mar;102(3):533–543. [PubMed] [Google Scholar]
  20. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  21. Shin H. S., Smith M. R., Wood W. B., Jr Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. J Exp Med. 1969 Dec 1;130(6):1229–1241. doi: 10.1084/jem.130.6.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tamura N., Nelson R. A., Jr Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol. 1967 Sep;99(3):582–589. [PubMed] [Google Scholar]
  23. Wellek B., Opferkuch W. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle. Clin Exp Immunol. 1975 Feb;19(2):223–235. [PMC free article] [PubMed] [Google Scholar]
  24. Wolski K. P., Schmid F. R., Mittal K. K. Genetic linkage between the HL-A system and a deficit of the second component (C2) of complement. Science. 1975 Jun 6;188(4192):1020–1022. doi: 10.1126/science.1145185. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES